Downregulation of occludin affects the proliferation, apoptosis and metastatic properties of human lung carcinoma.

Abstract:

:Lung cancer is the most frequent and deadliest cancer in the world, especially in China. However, the molecular mechanisms involved in lung cancer remain unclear. Occludin (OCLN), one of the first identified tight junction proteins, has been revealed to be a necessary integral protein for tight junction structure and function. In the present study, we investigated the role of occludin in lung tumorigenesis. We found that occludin protein expression was highly increased in human lung cancer patient samples. Western blotting results also revealed that occludin expression was different in several lung cancer cell lines, with the highest level in SPC‑A1 cells. Moreover, occludin knockdown inhibited lung cancer cell proliferation in vitro and in vivo. In addition, occludin knockdown promoted the apoptosis of lung cancer cell lines and reduced the invasion ability. Mechanistically, the activity of key growth pathway AKT/PI3K was compromised after occludin knockdown. Expression of apoptosis‑related proteins, BAX, caspase‑3, caspase‑9 and AIF, but not Bcl‑2, were upregulated after silencing of occludin. Collectively, our findings for the first time identify the role of occludin as a tumor promoter and a pro‑metastatic factor in lung cancer, demonstrating that occludin is a potential prognostic biomarker and therapeutic target in lung cancer.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Wang M,Liu Y,Qian X,Wei N,Tang Y,Yang J

doi

10.3892/or.2018.6408

subject

Has Abstract

pub_date

2018-07-01 00:00:00

pages

454-462

issue

1

eissn

1021-335X

issn

1791-2431

journal_volume

40

pub_type

杂志文章
  • Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.

    abstract::Survivin, an anti-apoptotic protein, is abundantly expressed in a variety of cancer cells, including hepatoma cells, resulting in the resistance of these cells to various apoptotic stimuli. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is known to induce cancer cell-specific apoptosis, but hepa...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Nakao K,Hamasaki K,Ichikawa T,Arima K,Eguchi K,Ishii N

    更新日期:2006-08-01 00:00:00

  • Down-regulation of MTUS1 in human colon tumors.

    abstract::Loss of proliferative control and failure to undergo cellular differentiation are key events during carcinogenesis. We recently identified a new potential tumor suppressor gene named MTUS1 (mitochondrial tumor suppressor 1), down-regulated in undifferentiated tumor cell lines, inhibiting tumor cell proliferation after...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Zuern C,Heimrich J,Kaufmann R,Richter KK,Settmacher U,Wanner C,Galle J,Seibold S

    更新日期:2010-01-01 00:00:00

  • Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.

    abstract::The aim of this study was to better understand the mechanisms of tumor development and disease progression in human epithelial ovarian cancer. Fifty genes were screened for gene signature; 20 expressed genes were assessed in tumor and normal samples of EOC patients by RT-PCR. Expres...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1483

    authors: Guo Y,Fu P,Zhu H,Reed E,Remick SC,Petros W,Mueller MD,Yu JJ

    更新日期:2012-01-01 00:00:00

  • Oxymatrine inhibits epithelial-mesenchymal transition through regulation of NF-κB signaling in colorectal cancer cells.

    abstract::Oxymatrine, a traditional Chinese herb extracted from Sophora flavescens Ait., displays strong anti-inflammatory and anticancer activities, but how oxymatrine exhibits anticarcinogenic effects in human colorectal cancer (CRC) remains uncertain. The present study aimed to elucidate the exact mechanism by which oxymatri...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4927

    authors: Liang L,Huang J

    更新日期:2016-09-01 00:00:00

  • Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein.

    abstract::A growing number of studies suggest that the hepatitis B virus X protein (HBx) enhances the protein stability of the hypoxia-inducible factor-1α (HIF-1α). However, the relationship between hepatitis B virus (HBV), HBx and hypoxia-inducible factor-2α (HIF-2α) has not yet been fully elucidated. Immunohistochemical analy...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4480

    authors: Hu JL,Liu LP,Yang SL,Fang X,Wen L,Ren QG,Yu C

    更新日期:2016-03-01 00:00:00

  • The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.

    abstract::Human glioblastoma is a malignant and aggressive primary human brain solid tumor characterized by severe hypoxia. Hypoxia can induce autophagy, which may result in chemoresistance and malignant progression of cancer cells. MicroRNAs (miRNAs) have been reported to modulate hypoxia‑induced autophagy in various types of ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6929

    authors: Huang S,Qi P,Zhang T,Li F,He X

    更新日期:2019-03-01 00:00:00

  • L‑Deprenyl exerts cytotoxicity towards acute myeloid leukemia through inhibition of mitochondrial respiration.

    abstract::The identification of large numbers of genetic mutations in immature myeloid cells has made it difficult to identify specific targets for acute myeloid leukemia (AML) therapy. Although current pharmacological targets for controlling cancer are focused on identifying genetic mutations, it is hard to develop the specifi...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6753

    authors: Ryu I,Ryu MJ,Han J,Kim SJ,Lee MJ,Ju X,Yoo BH,Lee YL,Jang Y,Song IC,Chung W,Oh E,Heo JY,Kweon GR

    更新日期:2018-12-01 00:00:00

  • NRF2 is overexpressed in ovarian epithelial carcinoma and is regulated by gonadotrophin and sex-steroid hormones.

    abstract::Aberrant nuclear factor-erythroid 2 (NRF2) expression correlates with tumor development. We investigated NRF2 expression in ovarian epithelial carcinoma (OEC), aiming to identify associations with clinicopathological factors, hormones and induced reactive oxygen species (ROS). Immun...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1700

    authors: Liao H,Zhou Q,Zhang Z,Wang Q,Sun Y,Yi X,Feng Y

    更新日期:2012-06-01 00:00:00

  • Bioinformatic analysis of the membrane cofactor protein CD46 and microRNA expression in hepatocellular carcinoma.

    abstract::The therapeutic potential of membrane complement regulatory protein (mCRP)-neutralizing antibodies is unsatisfactory, which perhaps lies in the complex role of mCRPs in tumor occurrence and development. As a member of the mCRPs, CD46 is a transmembrane protein with a cytoplasmic domain and is implicated more in the co...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2877

    authors: Lu Z,Zhang C,Cui J,Song Q,Wang L,Kang J,Li P,Hu X,Song H,Yang J,Sun Y

    更新日期:2014-02-01 00:00:00

  • Long non-coding RNA SNHG1 predicts a poor prognosis and promotes colon cancer tumorigenesis.

    abstract::Colon cancer is the main cause of cancer mortality worldwide. Its poor prognosis is mainly ascribed to high recurrence rates. Identifying novel prognostic biomarkers and therapeutic key points for management is crucial and important. Long non-coding RNAs (lncRNAs) are a class of RNAs, which have various roles in carci...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6412

    authors: Yang H,Wang S,Kang YJ,Wang C,Xu Y,Zhang Y,Jiang Z

    更新日期:2018-07-01 00:00:00

  • The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance.

    abstract::Multidrug resistance (MDR) to chemotherapeutic drugs is the main cause of chemotherapy failure in cancer treatment, and it generally results from expression of ATP-dependent efflux pump P-glycoprotein (P-gp). MDR reversal agents typically act by inhibiting the drug efflux activity of P-gp, thereby increasing intracell...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3326

    authors: Cao Z,Wright M,Cheng J,Huang X,Liu L,Wu L,Yang P

    更新日期:2014-09-01 00:00:00

  • Genetically modified tumour vaccines producing IL-12 augment chemotherapy of HPV16-associated tumours with gemcitabine.

    abstract::Genetically modified tumour cells producing cytokines such as interleukin 12 (IL-12) are potent activators of the antitumour immune responses and represent a promising therapeutic modality when combined with chemotherapy. The objective of this study was to examine whether IL-12-producing cellular vaccines can augment ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1221

    authors: Mikyšková R,Indrová M,Símová J,Bieblová J,Bubeník J,Reiniš M

    更新日期:2011-06-01 00:00:00

  • Effect of brefeldin A and castanospermine on resistant cell lines as supplements in anticancer therapy.

    abstract::In the present study, we analyzed the influence of brefeldin A (BFA) and castanospermine (CAS) on the activity, stability and localization of P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) in various resistant cell lines. The impact of BFA and CAS on cell viability was assessed using the MTT test. We...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4656

    authors: Wojtowicz K,Januchowski R,Sosińska P,Nowicki M,Zabel M

    更新日期:2016-05-01 00:00:00

  • SETDB1 induces epithelial‑mesenchymal transition in breast carcinoma by directly binding with Snail promoter.

    abstract::SET domain bifurcated 1 (SETDB1) is a histone H3 lysine 9 methyltransferase that is highly expressed in various tumor types, including breast cancer. However, how SETDB1 functions in breast cancer is unclear. In the present study, proliferation, migration and invasion assays were performed to explore the role of SETDB...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6871

    authors: Yang W,Su Y,Hou C,Chen L,Zhou D,Ren K,Zhou Z,Zhang R,Liu X

    更新日期:2019-02-01 00:00:00

  • miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD.

    abstract::microRNAs (miRNAs), a class of small non-coding RNA molecules, can regulate gene expression by interacting with the 3'-untranslated regions (3'UTR) of target genes and influence various biological processes. We investigated the potential role of miR-24-3p in the development of bladder cancer by regulating DEDD, a memb...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5326

    authors: Yu G,Jia Z,Dou Z

    更新日期:2017-02-01 00:00:00

  • 5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells.

    abstract::We investigated the effects of combined treatment with 5-fluorouracil and apigenin on proliferation and apoptosis, as well as the underlying mechanism, in human breast cancer MDA-MB-453 cells. The MDA-MB-453 cells, which have been shown to overexpress ErbB2, were resistant to 5-fluorouracil; 5-fluorouracil exhibited a...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000598

    authors: Choi EJ,Kim GH

    更新日期:2009-12-01 00:00:00

  • The inhibitory effects of deep-sea water on doxorubicin‑induced epithelial-mesenchymal transition.

    abstract::It has been revealed that the induction of epithelial‑mesenchymal transition (EMT) is associated with drug resistance, leading to tumor recurrence and metastasis. Recent studies have shown that chemotherapeutic agents, besides their therapeutic effects, can induce EMT and enhance invasive and metastatic properties of ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5726

    authors: Chun SY,Kim S,Nam KS

    更新日期:2017-08-01 00:00:00

  • Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarray.

    abstract::Mutations in the epidermal growth factor receptor (EGFR) make lung adenocarcinoma cells sensitive to EGFR tyrosine kinase inhibitors (TKIs). Long-term cancer therapy may cause the occurrence of acquired resistance to EGFR TKIs. Long non-coding RNAs (lncRNAs) play important roles in tumor formation, tumor metastasis an...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4758

    authors: Wu Y,Yu DD,Hu Y,Yan D,Chen X,Cao HX,Yu SR,Wang Z,Feng JF

    更新日期:2016-06-01 00:00:00

  • Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.

    abstract::Cyclin‑dependent kinase 5 regulatory subunit‑​associated protein 3 (CDK5RAP3 or C53) is involved in the development of various types of tumor, and alternative splicing of C53 results in numerous transcription variants that encode different isoforms. The present study aimed to clone human C53 isoform d (IC53d) and expl...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7042

    authors: Lin JX,Xie XS,Weng XF,Qiu SL,Xie JW,Wang JB,Lu J,Chen QY,Cao LL,Lin M,Tu RH,Li P,Huang CM,Zheng CH

    更新日期:2019-05-01 00:00:00

  • Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway.

    abstract::Bmal1 is a core factor in the regulation of circadian rhythms. Previous studies have shown that Bmal1 suppresses tumor growth in cell culture and animal models and is downregulated in certain types of cancer. The aim of the present study was to investigated whether Bmal1 influences the invasiveness of cancer cells. We...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2381

    authors: Jung CH,Kim EM,Park JK,Hwang SG,Moon SK,Kim WJ,Um HD

    更新日期:2013-06-01 00:00:00

  • Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk.

    abstract::Previous studies have suggested that certain genetic polymorphisms, specifically the Xeroderma pigmentosum group D (XPD) gene codon 751 and the X-ray repair cross-complementing group 1 (XRCC1) gene codon 399 polymorphisms, were associated with an increased risk of lung cancer, and, in some studies, with a greater risk...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000854

    authors: Gao W,Romkes M,Zhong S,Nukui T,Persad RA,Smith PJ,Branch R,Keohavong P

    更新日期:2010-07-01 00:00:00

  • Esculetin inhibits cell proliferation through the Ras/ERK1/2 pathway in human colon cancer cells.

    abstract::Esculetin, a phenolic compound, has been shown to inhibit the growth of colon tumors in animal studies. However, the roles of signaling pathways and cell cycle regulation in the esculetin-induced inhibition of cancer cell growth, remain to be elucidated. The present study suggests a novel mechanism for the Ras/ERK1/2 ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Park SS,Park SK,Lim JH,Choi YH,Kim WJ,Moon SK

    更新日期:2011-01-01 00:00:00

  • Alternative lengthening of telomeres is induced by telomerase inhibitors in Barrett's esophageal cells.

    abstract::A crucial step in the path to the malignant transformation of cells and tumor formation is immortalization, which essentially depends on telomere maintenance. The aim of this study was to investigate the role of telomerase in the progression of Barrett's esophagus. Telomerase activi...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2238

    authors: Qin X,Qi B,Zhao B

    更新日期:2013-04-01 00:00:00

  • COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates.

    abstract::Cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF), and microvessel density (MVD) have been reported to be significantly related to carcinogenesis and to tumoral progression. The aim of the study was to analyse immunohistochemically the overexpression of COX-2 and VEGF, and the MVD between one another...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Raspollini MR,Amunni G,Villanucci A,Boddi V,Baroni G,Taddei A,Taddei GL

    更新日期:2004-02-01 00:00:00

  • Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus.

    abstract::hTERTC27, a 27-kDa hTERT C-terminal polypeptide has been demonstrated to cause hTERT-positive HeLa cell apoptosis and inhibits the growth of mouse melanoma. hTERTC27 has been associated with telomere dysfunction, regulation of gene-regulated apoptosis, the cell cycle and activation of natural killer (NK) cells, but it...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1619

    authors: Gong HX,He L,Li XP,Wang YD,Li Y,Huang JJ,Wang Z,Xie D,Kung HF,Peng Y

    更新日期:2012-04-01 00:00:00

  • Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.

    abstract::Acute lymphoblastic leukemia (ALL) is a malignant hematological disease. Tanshinone IIA (Tan IIA) has antitumor activity in vitro and in vivo. The aim of the present study was to investigate the effects of Tan IIA in combination with imatinib (IM) on the proliferation, apoptosis, migration and invasion of acute T lymp...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7453

    authors: Teng Z,Xu S,Lei Q

    更新日期:2020-02-01 00:00:00

  • Ribozyme mediated down-regulation of thrombospondin receptor CD36 inhibits the growth of the human osteosarcoma cell line.

    abstract::Thrombospondin-1 (TSP1) is known to possess tumor suppressor functions. In contradiction, TSP1 enhances the stromal vascularization and growth of certain cancers. A cell adhesion receptor, CD36, has been shown to interact with a ligand TSP1. We studied how CD36 affects the growth of the osteosarcoma cell line (HOS) ex...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yamazaki H,Handa A,Nishi M,Tokunaga T,Tomisawa M,Hatanaka H,Abe Y,Kijima H,Ueyama Y,Nakamura M

    更新日期:2004-02-01 00:00:00

  • miR-216b inhibits glioma cell migration and invasion through suppression of FoxM1.

    abstract::MicroRNAs (miRNAs) play a vital role in tumour biological and pathologic processes. In the present study, we aimed to detect the expression and biological role of miR-216b in glioma. Our data showed that miR-216b was significantly downregulated in human glioma tissues and cells. Ectopic expression of miR-216b inhibite...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5824

    authors: Zhang T,Ma G,Zhang Y,Huo H,Zhao Y

    更新日期:2017-09-01 00:00:00

  • Genome-wide cDNA microarray screening of genes related to survival in patients after curative resection of non-small cell lung cancer.

    abstract::We conducted a study to determine whether the expression levels of genes in tumors were correlated with the survival of patients after complete resection of non-small cell lung cancer (NSCLC). The expression levels of 1176 genes in resected tumor specimens from 28 patients were analyzed using the Atlastrade mark Human...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Oshita F,Sekiyama A,Ito H,Kameda Y,Miyagi Y

    更新日期:2006-10-01 00:00:00

  • Synergistic antitumor effect of JAWSII dendritic cells and interleukin 12 in a melanoma mouse model.

    abstract::One of the possible ways to augment dendritic cell (DC) efficacy in presentation of tumor antigens to effector T cells is pulsing them with tumor-cell lysates and incubation with certain immunostimulators. We present the results of an immunotherapeutic approach in a murine B78-H1 mo...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2193

    authors: Zapała Ł,Wolny R,Wachowska M,Jakóbisiak M,Lasek W

    更新日期:2013-03-01 00:00:00